Emerged HA and NA mutants of the pandemic influenza H1N1 viruses with increasing epidemiological significance in Taipei and Kaohsiung, Taiwan, 2009-10

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Kao, Chuan Liang ^a,b   Chan, Ta Chien ^a   Tsai, Chu Han ^b   Chu, Kuan Ying ^a   Chuang, Shu Fang ^a,b   Lee, Chang Chun ^a   Li, Zheng Rong Tiger ^a   Wu, Ko Wen ^c   Chang, Luan Yin ^a   Shen, Yea Huei ^d   Huang, Li Min ^a   Lee, Ping Ing ^a   Yang, ChingLai ^e   Compans, Richard ^e   Rouse, Barry T ^f   King, Chwan Chuen ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d YUAN'S GENERAL HOSPITAL   (Taiwan)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GLUTAMIC ACID; HEMAGGLUTININ; LYSINE; MUTANT PROTEIN; OSELTAMIVIR; SIALIDASE;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CHILD; CLUSTER ANALYSIS; CONTROLLED STUDY; EPIDEMIC; FEMALE; GENE FREQUENCY; HERD IMMUNITY; HUMAN; INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; POPULATION DENSITY; PREVENTIVE MEDICINE; SEROLOGY; SURVIVAL RATE; TAIWAN; VIRUS ISOLATION; VIRUS STRAIN; GENETICS; INFLUENZA; MUTATION; PATHOGENICITY; REAL TIME POLYMERASE CHAIN REACTION; VIROLOGY;

ORTHOMYXOVIRIDAE;

HEMAGGLUTININS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MUTATION; NEURAMINIDASE; REAL-TIME POLYMERASE CHAIN REACTION; TAIWAN;

EID: 84856690719     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031162     Document Type: Article

References (89)

1. Ginsberg M, Hopkins J, Maroufi A, Dunne G, Sunega DR, et al. (2009) Swine influenza A (H1N1) infection in two children-Southern California, March-April 2009. MMWR 58: 400-402.
2. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360: 2605-2615.
3. Smith GJ, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, et al. (2009) Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459: 1122-1125.
4. Drake JW, (1993) Rates of spontaneous mutation among RNA viruses. Proc Natl Acad Sci U S A 90: 4171-4175.
5. Ortín J, Nájera R, López C, Dávila M, Domingo E, (1980) Genetic variability of Hong Kong (H3N2) influenza viruses: spontaneous mutations and their location in the viral genome. Gene 11: 319-331.
6. Steinhauer DA, Skehel JJ, (2002) Genetics of influenza viruses. Annu Rev Genet 36: 305-332.
7. Zambon MC, (2001) The pathogenesis of influenza in humans. Rev Med Virol 11: 227-241.
8. de Wit E, Munster VJ, van Riel D, Beyer WE, Rimmelzwaan GF, et al. (2010) Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host. J Virol 84: 1597-1606.
9. Kobasa D, Wells K, Kawaoka Y, (2001) Amino acids responsible for the absolute sialidase activity of the influenza A virus neuraminidase: relationship to growth in the duck intestine. J Virol 75: 11773-11780.
10. Hughes MT, McGregor M, Suzuki T, Suzuki Y, Kawaoka Y, (2001) Adaptation of influenza A viruses to cells expressing low levels of sialic acid leads to loss of neuraminidase activity. J Virol 75: 3766-3770.
11. Boni MF, (2008) Vaccination and antigenic drift in influenza. Vaccine 26 (Suppl 3): C8-14.
12. Boni MF, Gog JR, Anderson V, Feldman MW, (2006) Epidemic dynamics and antigenic evolution in a single season of influenza A. Proc Biol Sci 273: 1307-1316.
13. Lee CW, Senne DA, Suarez DL, (2004) Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. J Virol 78: 8372-8381.
14. Zepeda HM, Perea-Araujo L, Zarate-Segura PB, Vázquez-Pérez JA, Miliar-García A, et al. (2010) Identification of influenza A pandemic (H1N1) 2009 variants during the first 2009 influenza outbreak in Mexico City. J Clin Virol 48: 36-39.
15. Glinsky GV, (2010) Genomic analysis of pandemic (H1N1) 2009 reveals association of increasing disease severity with emergence of novel hemagglutinin mutations. Cell Cycle 9: 958-970.
16. van der Vries E, Stelma FF, Boucher CA, (2010) Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus. N Engl J Med 363: 1381-1382.
17. Melidou A, Gioula G, Exindari M, Chatzidimitriou D, Diza E, et al. (2010) Molecular and phylogenetic analysis of the haemagglutinin gene of pandemic influenza H1N1 2009 viruses associated with severe and fatal infections. Virus Res 151: 192-199.
18. Puzelli S, Facchini M, Spagnolo D, De Marco MA, Calzoletti L, et al. (2010) Transmission of hemagglutinin D222G mutant strain of pandemic (H1N1) 2009 virus. Emerg Infect Dis 16: 863-865.
19. Maurer-Stroh S, Lee RT, Eisenhaber F, Cui L, Phuah SP, et al. (2010) A new common mutation in the hemagglutinin of the 2009 (H1N1) influenza A virus. PLoS Curr 2: RRN1162.
20. Dept. of Household Registration Affairs, M.O.I. Taiwan, R.O.C. (2009) Available: http://www.ris.gov.tw/zh_TW/37. Accessed 2112 Jan 10.
21. Ho TS, Wang SM, Liu CC, (2010) Historical Review of Pandemic Influenza A in Taiwan, 2009. Pediatr Neonatol 51: 83-88.
22. Huseh PR, Lee PI, Chiu AWH, Yen MY, (2010) Pandemic (H1N1) 2009 vaccination and class suspensions after outbreaks, Taipei City, Taiwan. Emerg Infect Dis 16: 1309-1311.
23. Huang WT, Hsu CC, Lee PI, Chuang JH, (2010) Mass psychogenic illness in nationwide in-school vaccination for pandemic influenza A(H1N1) 2009, Taiwan, November 2009-January 2010. Euro Surveill 15 (21): 19575.
24. Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR, (2001) Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 146: 2275-2289.
25. Lee SS, Wong NS, (2011) The clustering and transmission dynamics of pandemic influenza A (H1N1) 2009 cases in Hong Kong. J Infect 63 (4): 274-280.
26. Igarashi M, Ito K, Yoshida R, Tomabechi D, Kida H, et al. (2010) Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin. PLoS One 5 (1): e8553.
27. Yang H, Carney P, Stevens J, (2010) Structure and Receptor binding properties of a pandemic H1N1 virus hemagglutinin. PLoS Curr 2: RRN1152.
28. Bradley KC, Jones CA, Tompkins SM, Tripp RA, Russell RJ, et al. (2011) Comparison of the receptor binding properties of contemporary swine isolates and early human pandemic H1N1 isolates (Novel 2009 H1N1). Virology 413: 169-82.
29. WHO (2009) Available: http://www.who.int/csr/disease/swineflu/Influenza_Transmission_Zones.pdf . Accessed 2012 Jan 10.
30. Ekiert DC, Bhabha G, Elsliger MA, Friesen RH, Jongeneelen M, et al. (2009) Antibody recognition of a highly conserved influenza virus epitope. Science 324 (5924): 246-51.
31. Sui J, Hwang WC, Perez S, Wei G, Aird D, et al. (2009) Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 16: 265-273.
32. Archetti I, Horsfall FL, (1950) Persistent antigenic variation of influenza A virus after incomplete neutralizationin ovo with heterologus immune serum. J Exp Med 92: 441-462.
33. WHO (2009) Pandemic (H1N1) 2009 briefing note 17. Public health significance of virus mutation detected in Norway. 20 November. Available: http://www.who.int/csr/disease/swineflu/notes/briefing_20091120/en/. Accessed 2012 Jan 10.
34. Chan Paul KS, Lee N, Joynt GM, Choi KW, Cheung Jo LK, et al. (2011) Clinical and virological course of infection with haemagglutinin D222G mutant strain of 2009 pandemic influenza A (H1N1) virus. J Clin Virol 50: 320-324.
35. Xu L, Bao L, Lv Q, Deng W, Ma Y, et al. (2010) A single-amino-acid substitution in the HA protein changes the replication and pathogenicity of the 2009 pandemic A (H1N1) influenza viruses in vitro and in vivo. Virol J 7: 325-331.
36. Ye J, Sorrell EM, Cai Y, Shao H, Xu K, et al. (2010) Variations in the hemagglutinin of the 2009 H1N1 pandemic virus: potential for strains with altered virulence phenotype? PLoS Pathog 6 (10): e1001145.
37. Colman PM, Varghese JN, Laver WG, (1983) Structure of catalytic and antigenic sites in influenza A neuraminidase. Nature 303: 41-44.
38. Das SR, Puigbò P, Hensley SE, Hurt DE, Bennink JR, et al. (2010) Glycosylation focuses sequence variation in the influenza A virus H1 hemagglutinin globular domain. PLoS Pathog 6 (11): e1001211.
39. Cherry JL, Lipman DJ, Nikolskaya A, Wolf YI, (2009) Evolutionary dynamics of N-glycosylation sites of influenza virus hemagglutinin. PLoS Curr 1: RRN1001.
40. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y, (1992) Evolution and Ecology of Influenza A Viruses. Micobiol Rev 56: 152-179.
41. Rabadan R, Robins H, (2007) Evolution of the influenza a virus: some new advances. Evol Bioinform 3: 299-307.
42. Nelson MI, Holmes EC, (2007) The evolution of epidemic influenza. Nat Rev Genet 8: 196-205.
43. Kuroda M, Katano H, Nakajima N, Tobiume M, Ainai A, et al. (2010) Characterization of quasispecies of pandemic 2009 influenza A virus (A/H1N1/2009) by de novo sequencing using a next-generation DNA sequencer. PLoS One 5 (4): e10256.
44. Chen H, Wen X, To KK, Wang P, Tse H, et al. (2010) Quasispecies of the D225G substitution in the hemagglutinin of pandemic influenza A(H1N1) 2009 virus from patients with severe disease in Hong Kong, China. J Infect Dis 15: 201: 1517-21.
45. Brookes SM, Núñez A, Choudhury B, Matrosovich M, Essen SC, (2010) Replication, pathogenesis and transmission of pandemic (H1N1) 2009 virus in non-immune pigs. PLoS One 5 (2): e9068.
46. Poon LL, Chan KH, Chu DK, Fung CC, Cheng CK, et al. (2011) Viral genetic sequence variations in pandemic H1N1/2009 and seasonal H3N2 influenza viruses within an individual, a household and a community. J Clin Virol 52 (2): 146-150.
47. Rambaut A, Pybus OG, Nelson MI, Viboud C, Taubenberger JK, et al. (2008) The genomic and epidemiological dynamics of human influenza A virus. Nature 453: 615-619.
48. Ferguson NM, Galvani AP, Bush RM, (2003) Ecological and immunological determinants of influenza evolution. Nature 422: 428-433.
49. Kilander A, Rykkvin R, Dudman S, Hungnes O, (2010) Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010. Euro Surveill 15(9) pii: 19498.
50. Puzelli S, Facchini M, Spagnolo D, De Marco MA, Calzoletti L, et al. (2010) Zanetti A, Fumagalli R, Tanzi ML, Cassone A, Rezza G, Donatelli I; Surveillance Group for Pandemic A H1N1 2009 Influenza Virus in Italy. Transmission of hemagglutinin D222G mutant strain of pandemic (H1N1) 2009 virus. Emerg Infect Dis 16 (5): 863-865.
51. Malato L, Llavador V, Marmier E, Youssef J, Balick Weber C, et al. (2011) Pandemic influenza A(H1N1) 2009: molecular characterisation and duration of viral shedding in intensive care patients in Bordeaux, south-west France, May 2009 to January 2010. Euro Surveill 16(4) pii: 19776.
52. WHO (2010) Preliminary review of D222G amino acid substitution in the haemagglutinin of pandemic influenza A(H1N1) 2009 viruses. Wkly Epidemiol Rec 85 (4): 21-22.
53. Graham M, Liang B, Van Domselaar G, Bastien N, Beaudoin C, et al. (2011) Nationwide molecular surveillance of pandemic H1N1 influenza A virus genomes: Canada, 2009. PLoS One 6: e16087.
54. Ertek M, Durmaz R, Guldemir D, Altas AB, Albayrak N, et al. (2010) Epidemiological, demographic, and molecular characteristics of laboratory-confirmed pandemic influenza A (H1N1) virus infection in Turkey, May 15-November 30, 2009. Jpn J Infect Dis 63 (4): 239-245.
55. Jayaraman A, Pappas C, Raman R, Belser JA, Viswanathan K, et al. (2011) A single base-pair change in 2009 H1N1 hemagglutinin increases human receptor affinity and leads to efficient airborne viral transmission in ferrets. PLoS One 6 (3): e17616.
56. Barr IG, Cui L, Komadina N, Lee RT, Lin RT, (2010) A new pandemic influenza A(H1N1) genetic variant predominated in the winter 2010 influenza season in Australia, New Zealand and Singapore. Euro Surveill 15(42) pii: 19692.
57. Abe Y, Takashita E, Sugawara K, Matsuzaki Y, Muraki Y, et al. (2004) Hongo S Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin. J Virol 78 (18): 9605-9611.
58. Wang CC, Chen JR, Tseng YC, Hsu CH, Hung YF, et al. (2009) Glycans on influenza hemagglutinin affect receptor binding and immune response. Proc Natl Acad Sci U S A 106 (43): 18137-18142.
59. Blackburne BP, Hay AJ, Goldstein RA, (2008) Changing selective pressure during antigenic changes in human influenza H3. PLoS Pathog 4 (5): e1000058.
60. Nunes B, Pechirra P, Coelho A, Ribeiro C, Arraiolos A, Rebelo-de-Andrade H, (2008) Heterogeneous selective pressure acting on influenza B Victoria- and Yamagata-like hemagglutinins. J Mol Evol 67: 427-435.
61. Wilson IA, Cox NJ, (1990) Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol 8: 737-771.
62. Shih AC, Hsiao TC, Ho MS, Li WH, (2007) Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution. Proc Natl Acad Sci U S A 104: 6283-6288.
63. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, et al. (2009) Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science 325 (5937): 197-201.
64. Ikonen N, Haanpää M, Rönkkö E, Lyytikäinen O, Kuusi M, et al. (2010) Genetic diversity of the 2009 pandemic influenza A (H1N1) viruses in Finland. PLoS One 5: e13329.
65. Morlighem JÉ, Aoki S, Kishima M, Hanami M, Ogawa C, et al. (2011) Mutation analysis of 2009 pandemic influenza A(H1N1) viruses collected in Japan during the peak phase of the pandemic. PLoS One 6: e18956.
66. Pan C, Cheung B, Tan S, Li C, Li L, et al. (2010) Genomic signature and mutation trend analysis of pandemic (H1N1) 2009 influenza A virus. Plos One 5: e9549.
67. Nelson M, Spiro D, Wentworth D, Beck E, Fan J, et al. (2009) The early diversification of influenza A/H1N1pdm. PLoS Curr 1: RRN1126.
68. To KK, Chan KH, Li IW, Tsang TY, Tse H, et al. (2010) Viral load in patients infected with pandemic H1N1 2009 influenza A virus. J Med Virol 82: 1-7.
69. Li IW, Hung IF, To KK, Chan KH, Wong SS, et al. (2010) The natural viral load profile of patients with pandemic 2009 influenza A(H1N1) and the effect of oseltamivir treatment. Chest 137: 759-768.
70. Balcan D, Hu H, Goncalves B, Bajardi P, Poletto C, et al. (2009) Seasonal transmission potential and activity peaks of the new influenza A(H1N1): a Monte Carlo likelihood analysis based on human mobility. BMC Med 7: 45-56.
71. Chi CY, Liu CC, Lin CC, Wang HC, Cheng YT, et al. (2010) Preexisting antibody response against 2009 pandemic influenza H1N1 viruses in the Taiwanese population. Clin Vaccine Immunol 17 (12): 1958-1962.
72. Skountzou I, Koutsonanos DG, Kim JH, Powers R, Satyabhama L, et al. (2010) Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus. J Immunol 185 (3): 1642-1649.
73. Potter CW, (2001) A history of influenza. J Appl Microbiol 91: 572-579.
74. Ansart S, Pelat C, Boelle PY, Carrat F, Flahault A, et al. (2009) Mortality burden of the 1918-1919 influenza pandemic in Europe. Influenza Other Respi Viruses 3: 99-106.
75. Miller MA, Viboud C, Balinska M, Simonsen L, (2009) The signature features of influenza pandemics-implications for policy. N Engl J Med 360: 2595-2598.
76. Wen TH, Lin NH, Chao DY, Hwang KP, Kan CC, et al. (2010) Spatial-temporal patterns of dengue in areas at risk of dengue hemorrhagic fever in Kaohsiung, Taiwan, 2002. Int J Infect Dis 14 (4): e334-43.
77. Müller V, Maggiolo F, Suter F, Ladisa N, De Luca A, et al. (2009) Increasing clinical virulence in two decades of the Italian HIV epidemic. PLoS Pathog 5 (5): e1000454.
78. Mitchell T, Dee DL, Phares CR, Lipman HB, Gould LH, et al. (2011) Non-pharmaceutical interventions during an outbreak of 2009 pandemic influenza A (H1N1) virus infection at a large public university, April-May 2009. Clin Infect Dis 52 (Suppl 1): S138-45.
79. Lee VJ, Yap J, Cook AR, Chen MI, Tay JK, et al. (2010) Effectiveness of public health measures in mitigating pandemic influenza spread: a prospective sero-epidemiological cohort study. J Infect Dis 202: 1319-1326.
80. Huang JW, King CC, Yang JM, (2009) Co-evolution positions and rules for antigenic variants of human influenza A/H3N2 viruses. BMC Bioinformatics 10 (Suppl 1): S41.
81. Langley WA, Thoennes S, Bradley KC, Galloway SE, Talekar GR, et al. (2009) Single residue deletions along the length of the influenza HA fusion peptide lead to inhibition of membrane fusion function. Virology 394 (2): 321-330.
82. Ekiert DC, Bhabha G, Elsliger MA, Friesen RH, Jongeneelen M, et al. (2009) Antibody recognition of a highly conserved influenza virus epitope. Science 324 (5924): 246-251.
83. To KK, Hung IF, Li IW, Lee KL, Koo CK, et al. (2010) Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 50 (6): 850-9.
84. Ghedin E, Laplante J, DePasse J, Wentworth DE, Santos RP, et al. (2011) Deep sequencing reveals mixed infection with 2009 pandemic influenza A (H1N1) virus strains and the emergence of oseltamivir resistance. J Infect Dis 203 (2): 168-174.
85. Tsai KN, Chen GW, (2011) Influenza genome diversity and evolution. Microbes Infect 13 (5): 479-488.
86. Höper D, Hoffmann B, Beer M, (2011) A comprehensive deep sequencing strategy for full-length genomes of influenza a. PLoS One 6 (4): e19075.
87. Chan MC, Chan RW, Yu WC, Ho CC, Yuen KM, et al. (2010) Tropism and innate host responses of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro cultures of human conjunctiva and respiratory tract. Am J Pathol 176: 1828-1840.
88. Ozawa M, Basnet S, Burley LM, Neumann G, Hatta M, et al. (2011) Impact of amino acid mutations in PB2, PB1-F2, and NS1 on the replication and pathogenicity of pandemic (H1N1) 2009 influenza viruses. J Virol 85 (9): 4596-601.
89. Mehle A, Doudna JA, (2009) Adaptive strategies of the influenza virus polymerase for replication in humans. Proc Natl Acad Sci U S A 106 (50): 21312-6.